Cancer-Focused Biotechs Launch 2 IPOs Totaling $200M
Two cancer-focused biotechnology companies launched initial public offerings on Monday totaling $200 million, representing the latest of several venture-backed life science companies returning to the IPO pipeline after Labor Day....To view the full article, register now.
Already a subscriber? Click here to view full article